News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
364,151 Results
Type
Article (14600)
Company Profile (116)
Press Release (349435)
Section
Business (112862)
Career Advice (461)
Deals (18660)
Drug Delivery (28)
Drug Development (31386)
Employer Resources (49)
FDA (8859)
Job Trends (7711)
News (173358)
Policy (12454)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1327)
Allergies (36)
Alliances (34808)
ALS (20)
Alzheimer's disease (492)
Antibody-drug conjugate (ADC) (54)
Approvals (8868)
Artificial intelligence (209)
Autoimmune disease (1)
Automation (11)
Bankruptcy (130)
Best Places to Work (6552)
BIOSECURE Act (6)
Biosimilars (9)
Biotechnology (87)
Bladder cancer (20)
Brain cancer (10)
Breast cancer (101)
Cancer (857)
Cardiovascular disease (57)
Career advice (410)
Career pathing (8)
CAR-T (92)
Cell therapy (242)
Cervical cancer (6)
Clinical research (24502)
Collaboration (516)
Compensation (94)
Complete response letters (3)
COVID-19 (1150)
CRISPR (31)
C-suite (109)
Cystic fibrosis (49)
Data (804)
Decentralized trials (1)
Denatured (18)
Depression (14)
Diabetes (83)
Diagnostics (4878)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (67)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (13)
Earnings (38406)
Editorial (2)
Employer branding (8)
Employer resources (42)
Events (51013)
Executive appointments (333)
FDA (9355)
Featured Employer (27)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (412)
Gene editing (72)
Generative AI (23)
Gene therapy (151)
GLP-1 (214)
Government (1242)
Grass and pollen (1)
Guidances (22)
Healthcare (9923)
Huntington's disease (5)
IgA nephropathy (7)
Immunology and inflammation (24)
Indications (9)
Infectious disease (1217)
Inflammatory bowel disease (56)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (45)
Interviews (52)
IPO (8009)
IRA (8)
Job creations (1450)
Job search strategy (366)
Kidney cancer (3)
Labor market (7)
Layoffs (114)
Leadership (3)
Legal (2549)
Liver cancer (33)
Lung cancer (105)
Lymphoma (51)
Machine learning (2)
Management (16)
Manufacturing (153)
MASH (14)
Medical device (11435)
Medtech (11440)
Mergers & acquisitions (10928)
Metabolic disorders (184)
Multiple sclerosis (23)
NASH (3)
Neurodegenerative disease (23)
Neuropsychiatric disorders (2)
Neuroscience (654)
NextGen: Class of 2025 (3547)
Non-profit (1531)
Northern California (948)
Now hiring (8)
Obesity (81)
Opinion (77)
Ovarian cancer (32)
Pain (42)
Pancreatic cancer (34)
Parkinson's disease (56)
Partnered (9)
Patents (112)
Patient recruitment (41)
Peanut (25)
People (32637)
Pharmaceutical (17)
Phase I (9037)
Phase II (11039)
Phase III (7174)
Pipeline (375)
Podcasts (36)
Policy (25)
Postmarket research (527)
Preclinical (4048)
Press Release (66)
Prostate cancer (36)
Psychedelics (4)
Radiopharmaceuticals (156)
Rare diseases (130)
Real estate (3385)
Recruiting (19)
Regulatory (9337)
Reports (18)
Research institute (1273)
Resumes & cover letters (69)
Rett syndrome (2)
RNA editing (1)
RSV (19)
Schizophrenia (10)
Series A (77)
Series B (45)
Service/supplier (7)
Sickle cell disease (16)
Southern California (1008)
Special edition (1)
Sponsored (13)
Startups (2509)
State (2)
Stomach cancer (1)
Supply chain (19)
The Weekly (17)
United States (9935)
Vaccines (297)
Venture capitalists (18)
Webinars (7)
Weight loss (34)
Women's health (16)
Worklife (2)
Date
Today (84)
Last 7 days (387)
Last 30 days (1509)
Last 365 days (18246)
2025 (2988)
2024 (18763)
2023 (22161)
2022 (30917)
2021 (32589)
2020 (30663)
2019 (25888)
2018 (19533)
2017 (18938)
2016 (17862)
2015 (20635)
2014 (15232)
2013 (12788)
2012 (13839)
2011 (14120)
2010 (12869)
Location
Africa (320)
Alabama (37)
Alaska (6)
Arizona (111)
Arkansas (9)
Asia (23987)
Australia (4177)
California (2449)
Canada (936)
China (198)
Colorado (144)
Connecticut (120)
Delaware (34)
Europe (48989)
Florida (402)
Georgia (116)
Idaho (35)
Illinois (248)
India (8)
Indiana (142)
Iowa (4)
Japan (87)
Kansas (79)
Kentucky (6)
Louisiana (5)
Maine (19)
Maryland (408)
Massachusetts (1736)
Michigan (173)
Minnesota (222)
Mississippi (2)
Missouri (52)
Montana (24)
Nebraska (16)
Nevada (19)
New Hampshire (64)
New Jersey (769)
New Mexico (15)
New York (722)
North Carolina (478)
North Dakota (7)
Northern California (948)
Ohio (92)
Oklahoma (10)
Oregon (18)
Pennsylvania (503)
Puerto Rico (4)
Rhode Island (17)
South America (505)
South Carolina (12)
South Dakota (1)
Southern California (1008)
Tennessee (51)
Texas (386)
Utah (92)
Virginia (49)
Washington D.C. (10)
Washington State (292)
West Virginia (3)
Wisconsin (32)
364,151 Results for "quad technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nanalysis Enters into a Letter of Intent to Acquire Quad Systems AG
Nanalysis Scientific Corp. is pleased to announce that it has entered into a letter of intent to acquire QUAD Systems AG, a Zurich-based Nuclear Magnetic Resonance company focused on high-field NMR for pharmaceutical and other vertical markets.
January 18, 2022
·
7 min read
Biotech Bay
AbTherx Opens Antibody Discovery Technologies Research Center
AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the opening of its new antibody discovery technologies research center.
June 18, 2024
·
3 min read
Business
Quad M Solutions Inc,. Announces Management and Board of Directors Changes
Quad M Solutions Inc. (OTC.PK: MMMM) has appointed Joseph Frontiere and Douglas Cole to its Board of Directors with Mr. Frontiere appointed its new Interim CEO.
August 11, 2021
·
4 min read
Press Releases
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq’s Novel Surface Treatment Technology
February 19, 2025
·
3 min read
Artificial intelligence
FDA’s New AI Guidance Highlights Risks of Technology, Urges Early Sponsor Engagement
The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information regarding models’ development and maintenance.
January 7, 2025
·
2 min read
·
Tristan Manalac
Smith+Nephew Sports Medicine advances procedural innovation by launching the QUADTRAC™ Quadriceps Tendon Harvest Guide System and expanded family of ULTRABUTTON™ Adjustable Fixation Devices for ACL reconstruction
Smith+Nephew, the global medical technology company, introduced the UltraTRAC™ QUAD ACL Reconstruction Technique which consists of the new QUADTRAC Quadriceps Tendon Harvest Guide System, X-WING™ Graft Preparation System and family of ULTRABUTTON Adjustable Fixation Devices.
March 7, 2023
·
7 min read
Press Releases
Hemostemix Licenses CytoImmune’s BioReactor Technologies
February 19, 2025
·
9 min read
Press Releases
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure
February 9, 2025
·
2 min read
Press Releases
RETRANSMISSION: Hemostemix Licenses CytoImmune’s BioReactor Technologies
February 20, 2025
·
9 min read
Press Releases
EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements
February 28, 2025
·
3 min read
1 of 36,416
Next
